Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol McCormick

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
BMJ Open|November 26, 2016
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studySelina Tsim, Caroline Kelly, Laura Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
British Journal of Cancer|December 19, 2025
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
British Journal of Cancer|November 17, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
BMJ Open|November 26, 2016
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studySelina Tsim, Caroline Kelly, Laura Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
British Journal of Cancer|December 19, 2025
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
British Journal of Cancer|November 17, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
Pageof 2